Colorectal Cancer Risk and Screening in Geriatric Patients

  • Elissa LinEmail author
  • Seymour Katz


The complexity of managing the elderly inflammatory bowel disease (IBD) patient encumbered by multiple comorbidities, polypharmacy, and physical and cognitive barriers is further compromised by the ever-present threat of malignancy. This review will attempt to provide the background of pathophysiologic components that are at work in the elderly with IBD. This chapter provides an overview of the epidemiology of colorectal cancer (CRC) in the elderly and discusses risk factors for CRC that pertain to the geriatric population with IBD. This chapter covers techniques utilized for colorectal cancer screening and identifies screening options that may help overcome the challenges of performing procedures in the elderly. Barriers to pursuing colonoscopy in the elderly are discussed. The experience to date of management is reviewed. This chapter also emphasizes consideration of frailty in the elderly population when deciding whether or not to pursue colonoscopy. Clinical guides, which are necessary for therapeutic decisions in this highly complex population, are updated.


Geriatric Elderly Colorectal cancer screening Colonoscopy Inflammatory bowel disease Frailty 


  1. 1.
    Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975–2015. National Cancer Institute; 2018. Available from:
  2. 2.
    Society AC. Colorectal cancer screening guidelines: American Cancer Society, Inc.; 2018. Available from:
  3. 3.
    Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Gaidos JK, Bickston SJ. How to optimize colon cancer surveillance in inflammatory bowel disease patients. Inflamm Bowel Dis. 2016;22(5):1219–30.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee SY, Song WH, Oh SC, Min BW, Lee SI. Anatomical distribution and detection rate of colorectal neoplasms according to age in the colonoscopic screening of a Korean population. Ann Surg Treat Res. 2018;94(1):36–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Maratt JK, Dickens J, Schoenfeld PS, Elta GH, Jackson K, Rizk D, et al. Factors associated with surveillance adenoma and sessile serrated polyp detection rates. Dig Dis Sci. 2017;62(12):3579–85.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11(2):172–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Mouchli MA, Ouk L, Scheitel MR, Chaudhry AP, Felmlee-Devine D, Grill DE, et al. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer. World J Gastroenterol. 2018;24(8):905–16.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Kahi CJ, Myers LJ, Slaven JE, Haggstrom D, Pohl H, Robertson DJ, et al. Lower endoscopy reduces colorectal cancer incidence in older individuals. Gastroenterology. 2014;146(3):718–25.e3.PubMedCrossRefGoogle Scholar
  11. 11.
    Esteva M, Ruiz A, Ramos M, Casamitjana M, Sanchez-Calavera MA, Gonzalez-Lujan L, et al. Age differences in presentation, diagnosis pathway and management of colorectal cancer. Cancer Epidemiol. 2014;38(4):346–53.PubMedCrossRefGoogle Scholar
  12. 12.
    Iida Y, Kawai K, Tsuno NH, Ishihara S, Yamaguchi H, Sunami E, et al. Proximal shift of colorectal cancer along with aging. Clin Colorectal Cancer. 2014;13(4):213–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Bouvier AM, Launoy G, Bouvier V, Rollot F, Manfredi S, Faivre J, et al. Incidence and patterns of late recurrences in colon cancer patients. Int J Cancer. 2015;137(9):2133–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers. 2013;5(2):676–713.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, et al. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol. 2013;37(3):278–83.PubMedCrossRefGoogle Scholar
  16. 16.
    Gathirua-Mwangi WG, Monahan P, Song Y, Zollinger TW, Champion VL, Stump TE, et al. Changes in adult BMI and waist circumference are associated with increased risk of advanced colorectal neoplasia. Dig Dis Sci. 2017;62(11):3177–85.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther. 2016;7(1):51–65.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther. 2014;39(5):459–77.PubMedCrossRefGoogle Scholar
  19. 19.
    Manosa M, Calafat M, de Francisco R, Garcia C, Casanova MJ, Huelin P, et al. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study. Aliment Pharmacol Ther. 2018;47(5):605–14.PubMedCrossRefGoogle Scholar
  20. 20.
    Dulai PS, Sandborn WJ, Gupta S. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prev Res (Philadelphia, PA). 2016;9(12):887–94.CrossRefGoogle Scholar
  21. 21.
    Wilson JC, Furlano RI, Jick SS, Meier CR. A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease. J Gastroenterol. 2016;51(11):1050–62.PubMedCrossRefGoogle Scholar
  22. 22.
    Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol. 2014;20(29):9872–81.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Herszenyi L, Barabas L, Miheller P, Tulassay Z. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis (Basel, Switzerland). 2015;33(1):52–7.CrossRefGoogle Scholar
  24. 24.
    Bojesen RD, Riis LB, Hogdall E, Nielsen OH, Jess T. Inflammatory bowel disease and small bowel cancer risk, clinical characteristics, and histopathology: a population-based study. Clin Gastroenterol Hepatol. 2017;15(12):1900–7.e2.PubMedCrossRefGoogle Scholar
  25. 25.
    Choi CR, Al Bakir I, Ding NJ, Lee GH, Askari A, Warusavitarne J, et al. Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study. Gut. 2017;68(3):[Epub].CrossRefGoogle Scholar
  26. 26.
    Taleban S, Elquza E, Gower-Rousseau C, Peyrin-Biroulet L. Cancer and inflammatory bowel disease in the elderly. Dig Liver Dis. 2016;48(10):1105–11.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Ricciuto A, Kamath BM, Griffiths AM. The IBD and PSC phenotypes of PSC-IBD. Curr Gastroenterol Rep. 2018;20(4):16.CrossRefGoogle Scholar
  28. 28.
    Folseraas T, Boberg KM. Cancer risk and surveillance in primary sclerosing cholangitis. Clin Liver Dis. 2016;20(1):79–98.PubMedCrossRefGoogle Scholar
  29. 29.
    Liu G, Lin J, Xie H, Shen B, Stocchi L, Liu X. Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis. Scand J Gastroenterol. 2015;50(11):1389–96.PubMedCrossRefGoogle Scholar
  30. 30.
    Pulusu SSR, Lawrance IC. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2017;11(8):711–22.PubMedCrossRefGoogle Scholar
  31. 31.
    Sorensen JO, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Belard E, et al. Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977–2011. Liver Int. 2018;38(3):532–41.PubMedCrossRefGoogle Scholar
  32. 32.
    Pickhardt PJ. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection. Abdom Radiol (New York). 2016;41(8):1441–4.CrossRefGoogle Scholar
  33. 33.
    Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. World J Gastroenterol. 2017;23(28):5086–96.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Kahi CJ, Pohl H, Myers LJ, Mobarek D, Robertson DJ, Imperiale TF. Colonoscopy and colorectal cancer mortality in the veterans affairs health care system: a case-control study. Ann Intern Med. 2018;168(7):481–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Doubeni CA, Corley DA, Quinn VP, Jensen CD, Zauber AG, Goodman M, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018;67(2):291–8.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Doroudi M, Schoen RE, Pinsky PF. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: which has the greatest impact on mortality? Cancer. 2017;123(24):4815–22.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Bevan RR, Rutter MD. Colorectal cancer screening – who, how, and when? Clin Endosc. 2018;51(1):37–49.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Duarte RB, Bernardo WM, Sakai CM, Silva GL, Guedes HG, Kuga R, et al. Computed tomography colonography versus colonoscopy for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018;14:349–60.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    van der Paardt MP, Stoker J. Magnetic resonance colonography for screening and diagnosis of colorectal cancer. Magn Reson Imaging Clin N Am. 2014;22(1):67–83.PubMedCrossRefGoogle Scholar
  40. 40.
    Graser A, Melzer A, Lindner E, Nagel D, Herrmann K, Stieber P, et al. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology. 2013;144(4):743–50.e2.PubMedCrossRefGoogle Scholar
  41. 41.
    Levine MS, Yee J. History, evolution, and current status of radiologic imaging tests for colorectal cancer screening. Radiology. 2014;273(2 Suppl):S160–80.PubMedCrossRefGoogle Scholar
  42. 42.
    Young GP, Symonds EL, Allison JE, Cole SR, Fraser CG, Halloran SP, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60(3):609–22.PubMedCrossRefGoogle Scholar
  43. 43.
    Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106–14.PubMedCrossRefGoogle Scholar
  44. 44.
    Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC perspective on colorectal cancer screening. N Engl J Med. 2018;378(18):1734–40.PubMedCrossRefGoogle Scholar
  45. 45.
    Di Lena M, Porcelli F, Altomare DF. Volatile organic compounds as new biomarkers for colorectal cancer: a review. Colorectal Dis. 2016;18(7):654–63.PubMedCrossRefGoogle Scholar
  46. 46.
    Cha JM, Suh M, Kwak MS, Sung NY, Choi KS, Park B, et al. Risk of interval cancer in fecal immunochemical test screening significantly higher during the summer months: results from the National Cancer Screening Program in Korea. Am J Gastroenterol. 2018;113(4):611–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287–97.PubMedCrossRefGoogle Scholar
  48. 48.
    Rex D. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307–23.PubMedCrossRefGoogle Scholar
  49. 49.
    Sole X, Crous-Bou M, Cordero D, Olivares D, Guino E, Sanz-Pamplona R, et al. Discovery and validation of new potential biomarkers for early detection of colon cancer. PLoS One. 2014;9(9):e106748.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Amal H, Leja M, Funka K, Lasina I, Skapars R, Sivins A, et al. Breath testing as potential colorectal cancer screening tool. Int J Cancer. 2016;138(1):229–36.PubMedCrossRefGoogle Scholar
  51. 51.
    Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L. Patients’ knowledge and fear of colorectal cancer risk in inflammatory bowel disease. J Dig Dis. 2016;17(6):383–91.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Kumar A. Effect of functional status on the quality of bowel preparation in elderly patients undergoing screening and surveillance colonoscopy. Gut Liver. 2016;10(4):569–73.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Senore C, Correale L, Regge D, Hassan C, Iussich G, Silvani M, et al. Flexible sigmoidoscopy and CT colonography screening: patients’ experience with and factors for undergoing screening-insight from the proteus colon trial. Radiology. 2018;286(3):873–83.PubMedCrossRefGoogle Scholar
  54. 54.
    Childers RE, Williams JL, Sonnenberg A. Practice patterns of sedation for colonoscopy. Gastrointest Endosc. 2015;82(3):503–11.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Lin OS. Performing colonoscopy in elderly and very elderly patients: risks, costs and benefits. World J Gastrointest Endosc. 2014;6(6):220–6.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Kanonidou Z, Karystianou G. Anesthesia for the elderly. Hippokratia. 2007;11(4):175–7.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Al-Zubaidi AM, Al-Shadadi AA, Alghamdy HU, Alzobady AH, Al-Qureshi LA, Al-Bakri IM. Retrospective comparison of sedated and non-sedated colonoscopy in an outpatient practice. Indian J Gastroenterol. 2016;35(2):129–32.PubMedCrossRefGoogle Scholar
  58. 58.
    Ogawa T, Ohda Y, Nagase K, Kono T, Tozawa K, Tomita T, et al. Evaluation of discomfort during colonoscopy with conventional and ultrathin colonoscopes in ulcerative colitis patients. Dig Endosc. 2015;27(1):99–105.PubMedCrossRefGoogle Scholar
  59. 59.
    Sofi AA, Nawras A, Khan MA, Howden CW, Lee WM. Meta-analysis of the performance of ultrathin vs. standard colonoscopes. Endoscopy. 2017;49(4):351–8.PubMedGoogle Scholar
  60. 60.
    Dorreen A, Heisler C, Jones J. Treatment of inflammatory bowel disease in the older patient. Inflamm Bowel Dis. 2018;24(6):1155–66.PubMedCrossRefGoogle Scholar
  61. 61.
    Razavi F, Gross S, Katz S. Endoscopy in the elderly: risks, benefits, and yield of common endoscopic procedures. Clin Geriatr Med. 2014;30(1):133–47.PubMedCrossRefGoogle Scholar
  62. 62.
    Johnson DA, Lieberman D, Inadomi JM, Ladabaum U, Becker RC, Gross SA, et al. Increased post-procedural non-gastrointestinal adverse events after outpatient colonoscopy in high-risk patients. Clin Gastroenterol Hepatol. 2017;15(6):883–91.e9.PubMedCrossRefGoogle Scholar
  63. 63.
    Garcia-Albeniz X, Hsu J, Bretthauer M, Hernan MA. Effectiveness of screening colonoscopy to prevent colorectal cancer among Medicare beneficiaries aged 70 to 79 years a prospective observational study. Ann Intern Med. 2017;166(1):18–26.PubMedCrossRefGoogle Scholar
  64. 64.
    Rathore F, Sultan N, Byrne D. Tolerance of colonoscopy and questioning its utility in the elderly population. Ir Med J. 2014;107(8):247.PubMedGoogle Scholar
  65. 65.
    Zhang J, Cheng Z, Ma Y, He C, Lu Y, Zhao Y, et al. Effectiveness of screening modalities in colorectal cancer: a network meta-analysis. Clin Colorectal Cancer. 2017;16(4):252–63.PubMedCrossRefGoogle Scholar
  66. 66.
    Yoshida N, Naito Y, Murakami T, Hirose R, Ogiso K, Inada Y, et al. Safety and efficacy of a same-day low-volume 1 L PEG bowel preparation in colonoscopy for the elderly people and people with renal dysfunction. Dig Dis Sci. 2016;61(11):3229–35.PubMedCrossRefGoogle Scholar
  67. 67.
    Saltzman JR, Cash BD, Pasha SF, Early DS, Muthusamy VR, Khashab MA, et al. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015;81(4):781–94.PubMedCrossRefGoogle Scholar
  68. 68.
    Moreno C, Kim DH, Bartel TB, Cash BD, Chang KJ, Feig BW, et al. ACR appropriateness criteria((R)) colorectal cancer screening. J Am Coll Radiol. 2018;15(5s):S56–s68.PubMedCrossRefGoogle Scholar
  69. 69.
    Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53(3):305–53.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Yu JX, East JE, Kaltenbach T. Surveillance of patients with inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2016;30(6):949–58.PubMedCrossRefGoogle Scholar
  71. 71.
    Huguet JM, Suárez P, Ferrer-Barceló L, et al. Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: review of general recommendations. World J Gastrointest Endosc. 2017;9(6):255–62.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Ten Hove JR, Mooiweer E, Dekker E, van der Meulen-de Jong AE, Offerhaus GJ, Ponsioen CY, et al. Low rate of dysplasia detection in mucosa surrounding dysplastic lesions in patients undergoing surveillance for inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2017;15(2):222–8.e2.PubMedCrossRefGoogle Scholar
  73. 73.
    Carballal S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, Vera MI, Marin-Garbriel JC, et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut. 2018;67(1):70–8.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113(4):481–517.PubMedCrossRefGoogle Scholar
  75. 75.
    Cohen-Mekelburg S, Schneider Y, Gold S, Scherl E, Steinlauf A. Advances in the diagnosis and management of colonic dysplasia in patients with inflammatory bowel disease. Gastroenterol Hepatol. 2017;13(6):357–62.Google Scholar
  76. 76.
    Lin JS, Piper MA, Perdue LA, Rutter C, Webber EM, O’Connor E, et al. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for colorectal cancer: a systematic review for the US Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality (US); 2016.PubMedCrossRefGoogle Scholar
  77. 77.
    Cha JM. Would you recommend screening colonoscopy for the very elderly? Intest Res. 2014;12(4):275–80.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017;9:CD000279.PubMedGoogle Scholar
  79. 79.
    Eluri S, Parian AM, Limketkai BN, Ha CY, Brant SR, Dudley-Brown S, et al. Nearly a third of high-grade dysplasia and colorectal cancer is undetected in patients with inflammatory bowel disease. Dig Dis Sci. 2017;62(12):3586–93.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    van Hees F, Saini SD, Lansdorp-Vogelaar I, Vijan S, Meester RG, de Koning HJ, et al. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. Gastroenterology. 2015;149(6):1425–37.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182–92.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Weigl K, et al. Strongly enhanced colorectal cancer risk stratification enhanced by combining family history and genetic risk scores. Clin Epidemiol. 2018;10:143–52.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Imperiale TF, Yu M, Monahan PO, Stump TE, Tabbey R, Glowinski E, et al. Risk of advanced neoplasia using the National Cancer Institute’s colorectal cancer risk assessment tool. J Natl Cancer Inst. 2017;109(1):1.CrossRefGoogle Scholar
  84. 84.
    Cha JM, Kozarek RA, La Selva D, Gluck M, Ross A, Chiorean M, et al. Risks and benefits of colonoscopy in patients 90 years or older, compared with younger patients. Clin Gastroenterol Hepatol. 2016;14(1):80–6.e1.PubMedCrossRefGoogle Scholar
  85. 85.
    Maratt JK, Lewis CL, Saffar D, Weston LE, Myers A, Piper MS, et al. Veterans’ attitudes towards deintensification of surveillance colonoscopy for low-risk adenomas. Clin Gastroenterol Hepatol. 2018;16(12):1999–2000.PubMedCrossRefGoogle Scholar
  86. 86.
    Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet (London, England). 2018;391(10132):1775–82.CrossRefGoogle Scholar
  87. 87.
    Toosizadeh N, Wendel C, Hsu C-H, Zamrini E, Mohler J. Frailty assessment in older adults using upper-extremity function: index development. BMC Geriatr. 2017;17(1):117.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.PubMedCrossRefGoogle Scholar
  89. 89.
    Cohan JN, Bacchetti P, Varma MG, Finlayson E. Outcomes after ileoanal pouch surgery in frail and older adults. J Surg Res. 2015;198(2):327–33.PubMedCrossRefGoogle Scholar
  90. 90.
    Qiu X, Ma J, Wang K, Zhang H. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis. Oncotarget. 2017;8(1):1031–45.PubMedGoogle Scholar
  91. 91.
    Zhu Z, Mei Z, Guo Y, Wang G, Wu T, Cui X, et al. Reduced risk of inflammatory bowel disease-associated colorectal neoplasia with use of thiopurines: a systematic review and meta-analysis. J Crohns Colitis. 2018;12(5):546–58.PubMedCrossRefGoogle Scholar
  92. 92.
    Khan N, Abbas AM, Lichtenstein GR, Loftus EV Jr, Bazzano LA. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Gastroenterology. 2013;145(5):1007–15.e3.CrossRefGoogle Scholar
  93. 93.
    Hagen JW, Pugliano-Mauro MA. Nonmelanoma skin cancer risk in patients with inflammatory bowel disease undergoing thiopurine therapy: a systematic review of the literature. Dermatol Sur. 2018;44(4):469–80.CrossRefGoogle Scholar
  94. 94.
    Hou JK, Feagins LA, Waljee AK. Characteristics and behavior of elderly-onset inflammatory bowel disease: a multi-center US study. Inflamm Bowel Dis. 2016;22(9):2200–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.New York University Langone HealthNew YorkUSA

Personalised recommendations